Patents Assigned to CAMRIS International, Inc.
  • Antigen for use in malaria
    Patent number: 11793868
    Abstract: The present invention provides polypeptides useful as antigens expressed at the pre-erythrocytic stage of the malaria parasite. The antigens can be utilized to induce an immune response and sterile protection against malaria in a mammal by administering the antigens in vaccine formulations or expressing the antigens in DNA or other recombinant protein expression systems delivered as a vaccine formulation.
    Type: Grant
    Filed: December 21, 2018
    Date of Patent: October 24, 2023
    Assignee: CAMRIS International, Inc.
    Inventor: Joao Carlos Aguiar
  • Universal antivenom
    Patent number: 10961276
    Abstract: The present disclosure is directed to a universal antivenom for the treatment of venomous animal bites, and methods of developing the same using a novel targeted phage display technique.
    Type: Grant
    Filed: February 16, 2018
    Date of Patent: March 30, 2021
    Assignee: CAMRIS International, Inc.
    Inventor: Yoon Y. Hwang
  • UNIVERSAL ANTIVENOM
    Publication number: 20190382449
    Abstract: The present disclosure is directed to a universal antivenom for the treatment of venomous animal bites, and methods of developing the same using a novel targeted phage display technique.
    Type: Application
    Filed: February 16, 2018
    Publication date: December 19, 2019
    Applicant: CAMRIS International, Inc.
    Inventor: Yoon Y. HWANG
  • Antigen for use in malaria
    Patent number: 10195260
    Abstract: The present invention provides polypeptides useful as antigens expressed at the pre-erythrocytic stage of the malaria parasite. The antigens can be utilized to induce an immune response and sterile protection against malaria in a mammal by administering the antigens in vaccine formulations or expressing the antigens in DNA or other recombinant protein expression systems delivered as a vaccine formulation.
    Type: Grant
    Filed: February 13, 2017
    Date of Patent: February 5, 2019
    Assignee: CAMRIS International, Inc.
    Inventor: Joao Carlos Aguiar
  • NOVEL ANTIGEN FOR USE IN MALARIA
    Publication number: 20170232091
    Abstract: The present invention provides polypeptides useful as antigens expressed at the pre-erythrocytic stage of the malaria parasite. The antigens can be utilized to induce an immune response and sterile protection against malaria in a mammal by administering the antigens in vaccine formulations or expressing the antigens in DNA or other recombinant protein expression systems delivered as a vaccine formulation.
    Type: Application
    Filed: February 13, 2017
    Publication date: August 17, 2017
    Applicant: CAMRIS International, Inc.
    Inventor: Joao Carlos Aguiar